Literature DB >> 10636172

Remission of HIV myelopathy after highly active antiretroviral therapy.

R Staudinger1, K Henry.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10636172     DOI： 10.1212/wnl.54.1.267

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  8 in total

1.  Pilot study of intravenous immunoglobulin in HIV-associated myelopathy.

Authors:  Katia Cikurel; Lauren Schiff; David M Simpson
Journal:  AIDS Patient Care STDS       Date:  2009-02       Impact factor: 5.078

2.  Acute myelitis as presenting symptom of HIV-HTLV-1 co-infection.

Authors:  A Cucca; L Stragapede; L Antonutti; M Catalan; I Caracciolo; Romina Valentinotti; A Granato; P D'Agaro; P Manganotti
Journal:  J Neurovirol       Date:  2016-05-31       Impact factor: 2.643

Review 3.  Neurologic presentations of AIDS.

Authors:  Elyse J Singer; Miguel Valdes-Sueiras; Deborah Commins; Andrew Levine
Journal:  Neurol Clin       Date:  2010-02       Impact factor: 3.806

4.  Diffusion tensor MR imaging (DTI) metrics in the cervical spinal cord in asymptomatic HIV-positive patients.

Authors:  Christina Mueller-Mang; Meng Law; Thomas Mang; Julia Fruehwald-Pallamar; Michael Weber; Majda M Thurnher
Journal:  Neuroradiology       Date:  2010-11-03       Impact factor: 2.804

5.  Human immunodeficiency virus-associated vacuolar encephalomyelopathy with granulomatous-lymphocytic interstitial lung disease improved after antiretroviral therapy: a case report.

Authors:  Kazumasa Akagi; Kazuko Yamamoto; Asuka Umemura; Shotaro Ide; Tatsuro Hirayama; Takahiro Takazono; Yoshifumi Imamura; Taiga Miyazaki; Noriho Sakamoto; Hirokazu Shiraishi; Hideaki Takahata; Yoshiaki Zaizen; Junya Fukuoka; Minoru Morikawa; Kazuto Ashizawa; Katsuji Teruya; Koichi Izumikawa; Hiroshi Mukae
Journal:  AIDS Res Ther       Date:  2020-07-09       Impact factor: 2.250

6.  HIV-Associated Vacuolar Myelopathy and HIV-Associated Dementia as the Initial Manifestation of HIV/AIDS.

Authors:  Natalia Wuliji; Matthew J Mandell; Jason M Lunt; Adam Merando
Journal:  Case Rep Infect Dis       Date:  2019-09-15

7.  Atypical HIV-vacuolar myelopathy: a case report.

Authors:  Tau Mongezi; Joseph Sibi; George Jerry; Ibañez-Valdés Lourdes de Fátima; Dubula Tozama; Foyaca Sibat Humberto
Journal:  Eur J Med Res       Date:  2021-02-01       Impact factor: 2.175

8.  Successful Treatment of Human Immunodeficiency Virus-Associated Highly Active Antiretroviral Therapy-Resistant Vacuolar Myelopathy with Intravenous Immunoglobulin.

Authors:  Lidiia N Prakhova; Aleksandr G Ilves; Svetlana N Kizhlo; Zhanna I Savintseva
Journal:  Ann Indian Acad Neurol       Date:  2020-02-25       Impact factor: 1.383
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.